New Injectable Osteoporosis Drug Prolia Gains FDA Approval

Links shared publicly online about this topic.

  • 1,121
    total visits

New Injectable Osteoporosis Drug Prolia Gains FDA Approval

medicalnewstoday.com

Prolia, a new injectable drug to treat osteoporosis in postmenopausal women at high risk of fractures has been approved by the US Food and Drug Administration (FDA).In a statement on it

View full resource at medicalnewstoday.com

Tags: Emergency, Fracture, Osteoporosis, Osteoporosis Medication, Drug, Women's Health, FDA, Prolia

  • Share

Most Recently Shared on June 3, 2010 at 6:14 pm By:

mnt_menopause MNT Menopause

New Injectable Osteoporosis Drug Prolia Gains FDA Approval http://mnt.to/3Dvf #menopause

2 years ago...

Also Shared By:

MNT Health News MNT Health News

MNT Bones/Orthopedic MNT Bones/Orthopedic

MNT Drug Approvals MNT Drug Approvals

FDA approves new injectable osteoporosis treatment - San Francisco SF | Examiner.com

examiner.com — “The U.S. Food and Drug Administration (FDA) has approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at highView full resource at examiner.com

  • View Related
  • Share

Most Recently Shared on June 2, 2010 at 9:13 pm By:

sfseniorcare Liz Macera Nurse

FDA approves new injectable osteoporosis treatment - http://tinyurl.com/262heb4

2 years ago...

FDA Approves New Injectable Osteoporosis Treatment For Postmenopausal Women

medicalnewstoday.com — “The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures. Osteoporosis is a disease inView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 2, 2010 at 3:09 pm By:

mnt_drugapprov MNT Drug Approvals Health News

FDA Approves New Injectable Osteoporosis Treatment For Postmenopausal Women http://mnt.to/3DpW #regulatory

2 years ago...

FDA approves Amgen's osteoporosis drug Prolia | Booster Shots | Los Angeles Times

latimesblogs.latimes.com — “In a long-awaited development, the first drug in a new class of osteoporosis medications was approved Tuesday by the Food and Drug Administration. The drug is Amgen's injectable treatment, Prolia. The medication, for postmenopausal women with osteoporosis, is expected to...View full resource at latimesblogs.latimes.com

  • View Related
  • Share

Most Recently Shared on June 1, 2010 at 11:00 pm By:

Advertisement